Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

Byrd, John C ; Brown, Jennifer R ; O'Brien, Susan ; Barrientos, Jacqueline C ; Kay, Neil E ; Reddy, Nishitha M ; Coutre, Steven ; Tam, Constantine S ; Mulligan, Stephen P ; Jaeger, Ulrich ; Devereux, Steve ; Barr, Paul M ; Furman, Richard R ; Kipps, Thomas J ; Cymbalista, Florence ; Pocock, Christopher ; Thornton, Patrick ; Caligaris-Cappio, Federico ; Robak, Tadeusz ; Delgado, Julio ; Schuster, Stephen J ; Montillo, Marco ; Schuh, Anna ; de Vos, Sven ; Gill, Devinder ; Bloor, Adrian ; Dearden, Claire ; Moreno, Carol ; Jones, Jeffrey J ; Chu, Alvina D ; Fardis, Maria ; McGreivy, Jesse ; Clow, Fong ; James, Danelle F ; Hillmen, Peter

The New England journal of medicine, 2014-07, Vol.371 (3), p.213-223 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Rawstron, A C ; Böttcher, S ; Letestu, R ; Villamor, N ; Fazi, C ; Kartsios, H ; de Tute, R M ; Shingles, J ; Ritgen, M ; Moreno, C ; Lin, K ; Pettitt, A R ; Kneba, M ; Montserrat, E ; Cymbalista, F ; Hallek, M ; Hillmen, P ; Ghia, P

Leukemia, 2013-01, Vol.27 (1), p.142-149 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma

BARAN-MARSZAK, Fanny ; BOUKHIAR, Mohand ; LEDOUX, Dominique ; HAREL, Stéphanie ; LAGUILLIER, Christelle ; ROGER, Claudine ; GRESSIN, Remy ; MARTIN, Antoine ; FAGARD, Remi ; VARIN-BLANK, Nadine ; AJCHENBAUM-CYMBALISTA, Florence

Haematologica (Roma), 2010-11, Vol.95 (11), p.1865-1872 [Periódico revisado por pares]

Pavia: Ferrata Storti Foundation

Texto completo disponível

Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Brown, Jennifer R. ; Hillmen, Peter ; O’Brien, Susan ; Barrientos, Jaqueline C. ; Reddy, Nishitha ; Coutre, Steven ; Tam, Constantine ; Mulligan, Stephen ; Jaeger, Ulrich ; Barr, Paul M. ; Furman, Richard R. ; Kipps, Thomas J. ; Cymbalista, Florence ; Thornton, Patrick ; Caligaris-Cappio, Federico ; Delgado, Julio ; Montillo, Marco ; DeVos, Sven ; Moreno, Carol ; Pagel, John ; Burger, Jan A. ; Chung, Devon ; Lin, Jennifer ; Gau, Linda ; Chang, Betty ; McGreivy, Jesse ; James, Danelle F. ; Byrd, John C.

Blood, 2014-12, Vol.124 (21), p.3331-3331 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100

Le Roux, G ; Vlad, A ; Eclache, V ; Malanquin, C ; Collon, J-F ; Gantier, M ; Schillinger, F ; Peltier, J-Y ; Savin, B ; Letestu, R ; Baran-Marszak, F ; Fenaux, P ; Ajchenbaum-Cymbalista, Florence

International journal of laboratory hematology, 2010-12, Vol.32 (6 Pt 1), p.e237-e243 [Periódico revisado por pares]

England

Texto completo disponível

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation

Michallet, Mauricette ; Dreger, Peter ; Sutton, Laurent ; Brand, Ronald ; Richards, Sue ; van Os, Marleen ; Sobh, Mohamad ; Choquet, Sylvain ; Corront, Bernadette ; Dearden, Claire ; Gratwohl, Alois ; Herr, Wolfgang ; Catovsky, Daniel ; Hallek, Michael ; de Witte, Theo ; Niederwieser, Dietger ; Leporrier, Michel ; Milligan, Donald

Blood, 2011-02, Vol.117 (5), p.1516-1521 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Autoimmune Hemolytic Anemia and Immune Mediated Thrombocytopenia in the Phase III RESONATETM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Including a Case Report

Montillo, Marco ; O’Brien, Susan ; Tedeschi, Alessandra ; Hillmen, Peter ; Dearden, Claire ; Gill, Devinder ; Brown, Jennifer R. ; Barrientos, Jaqueline C. ; Mulligan, Stephen ; Furman, Richard R. ; Cymbalista, Florence ; Plascencia, Clara ; Chang, Stephen ; Hsu, Emily ; James, Danelle F. ; Byrd, John C.

Blood, 2014-12, Vol.124 (21), p.5654-5654 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Randomized comparison of ibrutinib versus ofatumumab in relapsed or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the phase III RESONATE trial

Byrd, John C. ; Brown, Jennifer R. ; O'Brien, Susan Mary ; Barrientos, Jacqueline Claudia ; Kay, Neil E. ; Reddy, Nishitha M. ; Coutre, Steven E. ; Tam, Constantine ; Mulligan, Stephen P. ; Jäger, Ulrich ; Devereux, Steve ; Barr, Paul M. ; Furman, Richard R. ; Kipps, Thomas J. ; Cymbalista, Florence ; Fardis, Maria ; McGreivy, Jesse S. ; Clow, Fong ; James, Danelle Frances ; Hillmen, Peter

Journal of clinical oncology, 2014-06, Vol.32 (18_suppl), p.LBA7008-LBA7008 [Periódico revisado por pares]

Texto completo disponível

Randomized comparison of ibrutinib versus ofatumumab in relapsed or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the phase III RESONATE trial

Byrd, John C. ; Brown, Jennifer R. ; O'Brien, Susan Mary ; Barrientos, Jacqueline Claudia ; Kay, Neil E. ; Reddy, Nishitha M. ; Coutre, Steven E. ; Tam, Constantine ; Mulligan, Stephen P. ; Jäger, Ulrich ; Devereux, Steve ; Barr, Paul M. ; Furman, Richard R. ; Kipps, Thomas J. ; Cymbalista, Florence ; Fardis, Maria ; McGreivy, Jesse S. ; Clow, Fong ; James, Danelle Frances ; Hillmen, Peter

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.LBA7008-LBA7008 [Periódico revisado por pares]

Texto completo disponível

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100TM

LE ROUX, G. ; VLAD, A. ; ECLACHE, V. ; MALANQUIN, C. ; COLLON, J.-F. ; GANTIER, M. ; SCHILLINGER, F. ; PELTIER, J.-Y. ; SAVIN, B. ; LETESTU, R. ; BARAN-MARSZAK, F. ; FENAUX, P. ; AJCHENBAUM-CYMBALISTA, F.

International journal of laboratory hematology, 2010-12, Vol.32 (6p1), p.e237-e243 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível